ation; however, the introduction of recombinant symIn Xenopus oocytes, several dormant mRNAs such as plekin to the depleted extracts failed to restore polyadthose encoding mos and cyclin B1 have short poly(A) enylation. Because symplekin immunodepletion also tails ‫02ف‬ bases in length. When the oocytes are stimuresulted in the loss of CPEB and CPSF from the extracts, lated to reenter the meiotic divisions, the tails on these this may explain why supplemental symplekin did not mRNAs elongate to ‫051-001ف‬ nucleotides, and translarestore polyadenylation. Surprisingly, complementation tion ensues. Cytoplasmic polyadenylation requires two of the depleted extract with symplekin, CPSF, and CPEB 3Ј UTR elements, AAUAAA and UUUUUAU (consensus), still did not stimulate polyadenylation. These observathe cytoplasmic polyadenylation element (CPE). The tions suggested that yet another essential polyadenyla-CPE is bound by the cytoplasmic polyadenylation eletion factor was codepleted with symplekin. An analysis of the factors associated with the symplekin-containing complex revealed the presence of the Xenopus homolog
suggest that the symplekin bound CPEB might be protected from destruction upon maturation and that it is Moreover, the immunodepleted symplekin-associated complex was able to polyadenylate RNA in an extraordithis pool of CPEB that is active in polyadenylation.
To investigate which interactions among CPEB, narily robust manner. Finally, xGLD-2 is anchored to the cytoplasmic polyadenylation complex through direct in-CPSF, and symplekin are direct, CPEB and symplekin were expressed in E. coli as fusion proteins with S tag teractions with both CPEB and CPSF in polyadenylationdeficient oocyte extracts as well as in polyadenylationon their amino termini. The S tag is a small peptide that has a strong binding affinity for S protein, which is affixed proficient egg extracts. These results not only suggest a revised model for how cytoplasmic polyadenylation is to agarose beads (Novagen). Thus, S-tagged CPEB and symplekin were immobilized on beads and used as affinregulated but have ramifications for cell cycle progression and neuronal synaptic plasticity, and other biologiity matrices to test for the binding of We have performed two sets of experiments to address trometry not only of maskin but also of a few other whether symplekin is required for CPE-mediated polyproteins. One of these proteins was identified through adenylation. First, symplekin antibody, or a control IgG, a single short peptide that until recently had no match was injected into Xenopus oocytes that were also inin the databases. However, a new BLAST search has jected with reporter RNAs that lacked or contained a identified this protein as the Xenopus homolog of sym-CPE. The oocytes were then induced to mature with plekin. Mammalian symplekin associates with CstF and progesterone; the RNA was isolated from the oocytes CPSF, two factors involved in nuclear pre-mRNA cleavand scored for polyadenylation by gel electrophoresis. age and polyadenylation (Takagaki and Manley, 2000; Figure 2A shows that, while progesterone stimulated Hofmann et al., 2002). A related protein in yeast, PTA1, robust polyadenylation of CPE-containing RNA even is a component of the polyadenylation machinery (Zhao when IgG was injected (lanes 4 and 6), there was a et al., 1999). In spite of these observations, however, dramatic reduction in both the length of the poly(A) tail the molecular function of symplekin in polyadenylation and the overall extent of polyadenylation when symis not known.
plekin antibody was injected (lane 6). As expected, the To verify the interaction between CPEB and symreduction of polyadenylation by symplekin antibody was plekin, we performed an additional coimmunoprecipitaaccompanied by the inhibition of progesterone-induced tion from Xenopus oocytes with CPEB antibody as well translation of mos mRNA, which serves as a marker for as a nonspecific IgG, which served as a control. The translation of CPE-containing mRNA ( Figure 2B , lane 4). Western blot in Figure 1A shows that symplekin was Symplekin antibody, or control IgG, was also added detected only when CPEB antibody was used for the to polyadenylation-competent egg extracts (Hake and coimmunoprecipitation (note that RNase A was included Richter, 1994; Stebbins-Boaz et al., 1996) . Only the symin all protein coimmunoprecipitation buffers). To confirm plekin antibody ablated the polyadenylation of CPEthis result, mRNA encoding myc-tagged CPEB was incontaining RNA in a dose-dependent manner (Figure jected into oocytes and subjected to myc antibody 2C). These data indicate that symplekin mediates polycoimmunoprecipitation. Compared to noninjected ooadenylation both in living cells and in cell lysates. cytes, from which no immunoprecipitated proteins were detected, both myc-CPEB and symplekin were found in the immunoprecipitates from the mRNA-injected ooImmunodepletion and Replacement of Symplekin: Ablation of Polyadenylation cytes. In a reciprocal experiment, endogenous CPEB but not mos, a negative control, was coprecipitated with but Not Restoration In a second set of experiments, we have sought to immusymplekin antibody ( Figure 1B ). In addition, CPSF was also coprecipitated symplekin, an observation made by nodeplete symplekin from egg extracts; if this procedure destroyed polyadenylation, as expected, then a restoraHofmann et al. (2002) as well, indicating that CPEB, symplekin, and CPSF might all reside in a common comtion of polyadenylation by replenishment with recombinant protein would be a clear demonstration of its imporplex. Interestingly, a coimmunoprecipitation with symplekin antibody from mature oocytes pulled down tance in this process. Figure 3A shows that, while mock immunodepletions with two different control IgGs had roughly the same amount of CPEB as from control (im- 35 S-methionine-labeled CPSF160 and symplekin were applied to columns containing S protein or S protein-CPEB and analyzed as in (C). Note that two proteins are produced by in vitro translation of symplekin mRNA; the faster migrating form could be due to downstream initiation, early termination, or protein breakdown. no effect on polyadenylation (lanes 3 and 5), symplekin and it too was clearly evident on the antibody beads. A nonspecific band that reacted with the CPSF100 antiantibody completely destroyed polyadenylation activity of the extract (lane 6). Unfortunately, polyadenylation body was neither depleted with the symplekin antibody nor evident on the antibody beads and thus serves as activity was not restored upon addition of a purified E. coli-expressed GST-symplekin fusion protein (lane 7). a control for the immunodepletion. Finally, almost all the CPEB was codepleted with the symplekin antibody, and While there could be a number of reasons for the lack of restored polyadenylation with supplemental symplekin, it too was clearly detected on the antibody beads. (Note that, in a reciprocal experiment with CPEB antibody, the protein-protein interaction data presented in Figure  1 made it seem likely that it was due to the codepletion only ‫%52ف‬ of the symplekin was coimmunoprecipitated [data not shown].) This result is not surprising, given that of CPEB, CPSF, and perhaps other proteins. To assess this possibility, the depleted extract as well as the antisymplekin is both nuclear and cytoplasmic in oocytes (Hofmann et al., 2002), while CPEB is exclusively cytobody-containing beads were probed for the presence of these proteins ( Figure 3B ). Nearly 90% of the symplasmic (Hake and Richter, 1994). Thus, the failure of recombinant symplekin to restore polyadenylation seemed plekin was depleted from the extract and was clearly evident on the antibody beads. Virtually all the CPSF likely due to the codepletion of these other proteins. To test this, symplekin antibody-depleted extracts, which 100 was also depleted with the symplekin antibody, (89%-90% similarity) and with the C. elegans protein to 43% (62% similarity) ( Figure 4A and data not shown). To initiate studies on xGLD-2, it was expressed in E. coli, were almost completely devoid of symplekin, CPSF, and purified, and used to generate antibody. Immunostain-CPEB ( Figure 3C ), were supplemented not only with ing of a Xenopus cell line (XTC) showed xGLD-2 is cytorecombinant symplekin but also with recombinant CPEB plasmic ( Figure 4B ), which is also the case with other and partially purified HeLa cell CPSF. However, the addimembers of this family of enzymes. While we were inition of these proteins still failed to rescue polyadenylatially unable to detect XGLD-2 in oocytes by Western tion activity ( Figure 3D) . While there were a number of blotting (see below), overexpressed protein did promote plausible explanations for this lack of reconstituted polypolyadenylation in oocytes even in the absence of proadenylation, we considered the most likely one to be gesterone. In contrast, an xGLD-2 containing an inactithe codepletion of yet another protein. One other protein vating D242A mutation in the catalytic domain (Kwak et that certainly is necessary for polyadenylation is poly(A) polymerase.
Identification of xGLD-2 as a Xenopus
al., 2004) elicited no response ( Figure 4C ). 
xGLD-2 Is a Component of the Cytoplasmic
To address whether xGLD-2 is involved with cytoplasmic polyadenylation, egg extracts were again subPolyadenylation Complex Based on the results in Figures 1-3 , as well as the sugjected to symplekin antibody immunodepletion, which as before removed most of the symplekin and CPSF. gested role of symplekin in nuclear polyadenylation (Takagaki and Manley, 2000), we surmised that symplekin xGLD-2 was not detected in the extract of total protein but was clearly concentrated on the antibody beads is a scaffold protein to which other components of the cytoplasmic polaydenylation machinery are attached. If ( Figure 5B ). The extract was supplemented with CPSF, CPEB, and symplekin as before, or these proteins plus true, a symplekin coimmunoprecipitate might be the best source to identify xGLD-2. Consequently, symeither wild-type (WT) xGLD-2 or xGLD-2 that contained the inactivating D242A mutation ( Figure 5C ). Strikingly, plekin was immunodepleted from oocyte extracts as before, and the antibody beads were probed not only wild-type xGLD-2 but not D242A xGLD-2 restored partial polyadenylation activity to the extract. xGLD-2 also for symplekin, CPSF100, and CPEB but for xGLD-2 as well ( Figure 5A ). While the presence of symplekin, mildly stimulated polyadenylation when added to a symplekin-depleted extract, which was probably due to the CPSF100, and CPEB on the beads was expected, we were surprised to detect xGLD-2 because oocyte exapproximately 10% of symplekin (as well as CPEB and CPSF) that remained in the extract. tracts do not polyadenylate RNA, and thus we would not expect it to be associated with the polyadenylation We also added substrate RNA to the complex of proteins concentrated on the symplekin antibody beads, machinery at this time. An identical symplekin immunodepletion from mature, polyadenylation-proficient egg which directed the synthesis of an enormously long poly(A) tail approaching 1500 bases in length (Figure extracts revealed the same spectrum of proteins in equal ratios as in oocyte extracts ( Figure 5A ). These experi-5D). This poly(A) tail is much longer than that observed in the unfractionated extract, which is ‫051ف‬ bases (lane ments reveal two important observations: that xGLD-2 resides in a complex containing other components of 2), suggesting that a regulator of poly(A) tail length was not coimmunoprecipitated with symplekin-containing the cytoplasmic polyadenylation machinery and that it is present in the complex even in the absence of polyadcomplex.
To address the specificity of xGLD-2 activity, WT or enylation. D242A mutant proteins were added to symplekin antipleted extracts, followed by incubation with CPE-lacking or CPE-containing RNA. While the CPE-lacking RNA body-depleted extracts that were supplemented with CPEB, CPSF, and symplekin. This mixture was then was not polyadenylated in the extract alone and minimally polyadenylated (i.e, ‫52ف‬ residues) in the extract incubated with RNA probes that lacked or contained a CPE. While the D242A mutant had no ability to restore plus WT xGLD-2 ( Figure 5F, compare lanes 3 and 4) , the CPE-containing RNA was strongly polyadenylated polyadenylation activity to the depleted extracts ( Figure  5E, lanes 4 and 8) , the WT GLD-2 stimulated polyadenylin the extract and even more so when xGLD-2 was added (compare lanes 6 and 7). In no case did the D242A ation of both RNAs (lanes 3 and 7) . However, the polyadenylation of the CPE-containing RNA was more robust; xGLD-2 mutant stimulate polyadenylation. Finally, we added xGLD-2 to extracts and tested the polyadenylait gained a mean tail length of ‫07ف‬ residues, while the CPE-lacking RNA gained a mean tail length of ‫52ف‬ resition of an "information-free" RNA derived from polylinker sequence, an RNA containing only an AAUAAA, or an dues. Because about 25 adenosine residues are necessary for an interaction with poly(A) binding protein RNA containing both a CPE and an AAUAAA. The polylinker and AAUAAA-containing RNAs gained only short (PABP) (Jacobson, 1996), which is essential for promoting CPEB-dependent translation in oocytes (Cao and poly(A) tails of ‫01ف‬ nucleotides, which, as noted previously, is very unlikely to stimulate translation. On the Richter, 2002), a "productive" polyadenylation that stimulates translation would require a poly(A) tail of about other hand, the CPE and AAUAAA-containing RNA gained a tail of greater than ‫05ف‬ nucleotides, which this length. Consequently, we infer that only poly(A) tails that are at least this long are likely to be biologically sigwould likely stimulate translation. These results show that, while xGLD-2 can stimulate polyadenylation of nificant.
We also added WT and mutant xGLD-2 to nonde-CPE-lacking RNA, its stimulation of CPE-containing RNA is much stronger. We surmise that a surfeit of umn to any appreciable extent. Thus, CPEB and CPSF probably act in concert to anchor xGLD-2 to the cytoxGLD-2 in the supplemented extract induced nonspeplasmic polyadenylation complex. cific polyadenylation of the CPE-lacking RNA.
Soon after oocytes are induced to mature with progesterone, Aurora A catalyzes CPEB phosphorylation on xGLD-2 Is Anchored to Polyadenylation serine 174, an event whose importance is underscored Machinery through CPEB and CPSF by the observations that (1) CPEB with an S174A mutaIn C. elegans, the interaction of GLD-2 with GLD-3, a tion prevents CPE-dependent polyadenylation and transsequence-specific RNA binding protein homologous to lation when oocytes are treated with progesterone, and Drosophila Bicaudal-C, dictates which mRNAs undergo (2) CPEB with an S174D mutation stimulates CPEpolyadenylation (Wang et al., 2002) . By analogy, xGLD-2 dependent polyadenylation and translation in untreated would also presumably interact with a sequence-speoocytes (Mendez et al., 2000a) . Serine 174 phosphorylacific RNA binding protein, in this case possibly CPEB. tion also enhances the affinity of CPEB for CPSF, sugAlternatively, perhaps CPSF, anchored to CPE-congesting that stable binding of these factors is important taining RNA through CPEB, would make direct contact for polyadenylation (Mendez et al., 2000b) . To determine with XGLD-2. To distinguish between these possibilities, whether S174 phosphorylation also modifies the interxGLD-2, or GST as a control, was expressed in E. coli action between CPEB and xGLD-2, reticulocyte-synas a fusion protein with S tag and immobilized on S thesized CPEB proteins containing S174A and S174D protein-agarose. In vitro-synthesized and 35 S-methomutations were applied to S protein-agarose beads connine-labeled CPSF160, CPEB, or symplekin (short and taining S-tagged xGLD-2. CPEB containing S174D was long forms as in Figure 1 ) was applied to the agarose employed not only because this mutation faithfully mimbeads, which were then washed extensively before eluics phospho-S174 but also because it was unlikely that tion with buffer containing 150 mM KCl, 250 mM KCl, an in vitro Aurora A kinase reaction would phosphorylate or SDS ( Figure 6A ). Interestingly, both CPEB and CPSF all of CPEB S174. Figure 6B shows that CPEB with but not symplekin strongly interacted with xGLD-2 and S174D had a 2-fold greater affinity for xGLD-2 than were not eluted from the column until SDS was applied.
CPEB with S174A (the S174A CPEB was used in this comparison to avoid a possible S174 phosphorylation None of the proteins bound to the GST-containing col- 
